Catalent
CTLT
#1737
Rank
A$17.34 B
Marketcap
A$95.57
Share price
0.00%
Change (1 day)
10.49%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): A-$9.66

According to Catalent's latest financial reports the company's current EPS (TTM) is A-$9.53. In 2023 the company made an earnings per share (EPS) of A-$10.24 a decrease over its 2022 EPS that were of A$3.42.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$9.66-5.67%
2023A-$10.24-399.56%
2022A$3.42-30.58%
2021A$4.9279.67%
2020A$2.74114.12%
2019A$1.28-15%
2018A$1.5175.44%
2017A$0.86-22.97%
2016A$1.11-59.56%
2015A$2.76282.05%
2014A$0.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
A-$0.50-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.13-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
A-$8.97-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
A-$2.23-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA